- Home
- ALXO vs NMS Comparison
ALXO vs NMS Comparison
Compare ALXO & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- NMS
- Stock Information
- Founded
- ALXO 2015
- NMS 1993
- Country
- ALXO United States
- NMS United States
- Employees
- ALXO N/A
- NMS N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- NMS Finance Companies
- Sector
- ALXO Health Care
- NMS Finance
- Exchange
- ALXO Nasdaq
- NMS Nasdaq
- Market Cap
- ALXO 76.5M
- NMS 71.0M
- IPO Year
- ALXO 2020
- NMS N/A
- Fundamental
- Price
- ALXO $1.74
- NMS $12.23
- Analyst Decision
- ALXO Buy
- NMS
- Analyst Count
- ALXO 6
- NMS 0
- Target Price
- ALXO $11.00
- NMS N/A
- AVG Volume (30 Days)
- ALXO 1.1M
- NMS 12.0K
- Earning Date
- ALXO 03-06-2025
- NMS 01-01-0001
- Dividend Yield
- ALXO N/A
- NMS 4.11%
- EPS Growth
- ALXO N/A
- NMS N/A
- EPS
- ALXO N/A
- NMS N/A
- Revenue
- ALXO N/A
- NMS N/A
- Revenue This Year
- ALXO N/A
- NMS N/A
- Revenue Next Year
- ALXO N/A
- NMS N/A
- P/E Ratio
- ALXO N/A
- NMS N/A
- Revenue Growth
- ALXO N/A
- NMS N/A
- 52 Week Low
- ALXO $1.19
- NMS $9.21
- 52 Week High
- ALXO $17.83
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- ALXO 53.13
- NMS 33.93
- Support Level
- ALXO $1.56
- NMS $12.20
- Resistance Level
- ALXO $1.94
- NMS $12.30
- Average True Range (ATR)
- ALXO 0.16
- NMS 0.14
- MACD
- ALXO -0.01
- NMS 0.01
- Stochastic Oscillator
- ALXO 50.00
- NMS 27.25
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.